Expertise in
12
conditions

Dr. Jorge Lascano

Intensive Care Medicine
Uf Health Medical Specialties-Medical Plaza
1549 Gale Lemerand Dr, 
Gainesville, FL 
Expertise in
12
conditions
Uf Health Medical Specialties-Medical Plaza
1549 Gale Lemerand Dr, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jorge Lascano is an Intensive Care Medicine provider in Gainesville, Florida. Dr. Lascano is highly rated in 12 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Subcutaneous Emphysema, Alpha-1 Antitrypsin Deficiency (AATD), Nontuberculous Mycobacterial Lung Disease, and Lung Transplant.

His clinical research consists of co-authoring 46 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in FL
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Uf Health Medical Specialties-Medical Plaza
1549 Gale Lemerand Dr, Gainesville, FL 32610
Call: 352-273-8740

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Multi-Center, Single-Dose and Repeat-Dose Over Eight Weeks, Sequential Cohort Study to Evaluate Safety and Tolerability as Well as Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% Administered Subcutaneously in Subjects With Alpha1-Antitrypsin Deficiency
A Multi-Center, Single-Dose and Repeat-Dose Over Eight Weeks, Sequential Cohort Study to Evaluate Safety and Tolerability as Well as Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% Administered Subcutaneously in Subjects With Alpha1-Antitrypsin Deficiency
Enrollment Status: Completed
Publish Date: December 12, 2025
Intervention Type: Biological
Study Drugs: Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human)
Study Phase: Phase 1/Phase 2
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease - Alpha-1 Biomarker Research Consortium (A1BC)
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease - Alpha-1 Biomarker Research Consortium (A1BC)
Enrollment Status: Active_not_recruiting
Publish Date: December 13, 2024
Early Markers of Subclinical Pulmonary Vascular Radiation Toxicity in Breast Cancer
Early Markers of Subclinical Pulmonary Vascular Radiation Toxicity in Breast Cancer
Enrollment Status: Completed
Publish Date: August 22, 2024
Intervention Type: Procedure, Radiation
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
Exhaled Breath Condensate for Evaluation of Lung Infections and Exacerbations in Patient With Cystic Fibrosis.
Exhaled Breath Condensate for Evaluation of Lung Infections and Exacerbations in Patient With Cystic Fibrosis.
Enrollment Status: Completed
Publish Date: August 25, 2023
Intervention Type: Other
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
Enrollment Status: Completed
Publish Date: June 28, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Enrollment Status: Completed
Publish Date: April 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

46 Total Publications

Epidemiology of Alpha-1 Antitrypsin Deficiency in the Veterans Health Administration.
Epidemiology of Alpha-1 Antitrypsin Deficiency in the Veterans Health Administration.
Journal: Annals of the American Thoracic Society
Published: August 07, 2025
View All 46 Publications
Similar Doctors
Expertise in
12
conditions
Dr. Ali Ataya
Intensive Care Medicine
Expertise in
12
conditions
Dr. Ali Ataya
Intensive Care Medicine

UF Health Pulmonary - Medical Specialties - Medical Plaza

1549 Gale Lemerand Dr, 
Gainesville, FL 
 (0.4 miles away)
352-273-8740
Languages Spoken:
English
See accepted insurances

Ali Ataya is an Intensive Care Medicine provider in Gainesville, Florida. Dr. Ataya is highly rated in 12 conditions, according to our data. His top areas of expertise are Pulmonary Alveolar Proteinosis, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Lung Transplant, and Fasciotomy.

Hiren Mehta
Expertise in
24
conditions
Dr. Hiren Mehta
Intensive Care Medicine
Expertise in
24
conditions
Dr. Hiren Mehta
Intensive Care Medicine

Uf Health Medical Lab-Shands Hospital

1600 SW Archer Rd, 
Gainesville, FL 
 (0.1 miles away)
352-273-8737
Languages Spoken:
English
See accepted insurances

Hiren Mehta is an Intensive Care Medicine provider in Gainesville, Florida. Dr. Mehta is highly rated in 24 conditions, according to our data. His top areas of expertise are Lung Nodules, Lung Cancer, Small Cell Lung Cancer (SCLC), Endoscopy, and Gastrostomy.

Expertise in
12
conditions
Dr. Borna Mehrad
Intensive Care Medicine
Expertise in
12
conditions
Dr. Borna Mehrad
Intensive Care Medicine

Uf Health Medical Specialties-Medical Plaza

1549 Gale Lemerand Dr, 
Gainesville, FL 
 (0.4 miles away)
352-273-8740
Languages Spoken:
English
See accepted insurances

Borna Mehrad is an Intensive Care Medicine provider in Gainesville, Florida. Dr. Mehrad is highly rated in 12 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pneumonia, Lung Transplant, and Tissue Biopsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lascano's expertise for a condition
ConditionClose
  • Elite
  • Cystic Fibrosis
    Dr. Lascano is
    Elite
    . Learn about Cystic Fibrosis.
    See more Cystic Fibrosis experts
  • Distinguished
  • Alpha-1 Antitrypsin Deficiency (AATD)
    Dr. Lascano is
    Distinguished
    . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
    See more Alpha-1 Antitrypsin Deficiency (AATD) experts
  • Emphysema
    Dr. Lascano is
    Distinguished
    . Learn about Emphysema.
    See more Emphysema experts
  • Nontuberculous Mycobacterial Lung Disease
    Dr. Lascano is
    Distinguished
    . Learn about Nontuberculous Mycobacterial Lung Disease.
    See more Nontuberculous Mycobacterial Lung Disease experts
  • Subcutaneous Emphysema
    Dr. Lascano is
    Distinguished
    . Learn about Subcutaneous Emphysema.
    See more Subcutaneous Emphysema experts
  • Advanced
  • Allergic Bronchopulmonary Aspergillosis
    Dr. Lascano is
    Advanced
    . Learn about Allergic Bronchopulmonary Aspergillosis.
    See more Allergic Bronchopulmonary Aspergillosis experts
  • Bronchiectasis
    Dr. Lascano is
    Advanced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Chronic Cough
    Dr. Lascano is
    Advanced
    . Learn about Chronic Cough.
    See more Chronic Cough experts
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Lascano is
    Advanced
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Newborn Jaundice
    Dr. Lascano is
    Advanced
    . Learn about Newborn Jaundice.
    See more Newborn Jaundice experts
  • Pulmonary Aspergilloma
    Dr. Lascano is
    Advanced
    . Learn about Pulmonary Aspergilloma.
    See more Pulmonary Aspergilloma experts
View All 7 Advanced Conditions
  • Experienced
  • Acute Interstitial Pneumonia
    Dr. Lascano is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Acute Respiratory Distress Syndrome (ARDS)
    Dr. Lascano is
    Experienced
    . Learn about Acute Respiratory Distress Syndrome (ARDS).
    See more Acute Respiratory Distress Syndrome (ARDS) experts
  • Aspergillosis
    Dr. Lascano is
    Experienced
    . Learn about Aspergillosis.
    See more Aspergillosis experts
  • Atypical Pneumonia
    Dr. Lascano is
    Experienced
    . Learn about Atypical Pneumonia.
    See more Atypical Pneumonia experts
  • Bronchogenic Cyst
    Dr. Lascano is
    Experienced
    . Learn about Bronchogenic Cyst.
    See more Bronchogenic Cyst experts
  • COVID-19
    Dr. Lascano is
    Experienced
    . Learn about COVID-19.
    See more COVID-19 experts
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Dr. Jorge Lascano
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.